Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-023-06990-4.pdf
Reference39 articles.
1. Yin L, Duan JJ, Bian XW, Yu SC (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22(1):61. https://doi.org/10.1186/s13058-020-01296-5
2. Belova L, Delgado B, Kocherginsky M, Melhem A, Olopade OI, Conzen SD (2009) Glucocorticoid receptor expression in breast cancer associates with older patient age. Breast Cancer Res Treat 116(3):441–447. https://doi.org/10.1007/s10549-008-0136-9
3. Abduljabbar R, Negm OH, Lai CF, Jerjees DA, Al-Kaabi M, Hamed MR et al (2015) Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast Cancer Res Treat 150(2):335–346. https://doi.org/10.1007/s10549-015-3335-1
4. Baker GM, Murphy T, Block T, Nguyen D, Lynch FJ (2015) Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer. Cancer Manag Res 7:361–368. https://doi.org/10.2147/CMAR.S91546
5. Obradovic M, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM et al (2019) Glucocorticoids promote breast cancer metastasis. Nature 567(7749):540–544. https://doi.org/10.1038/s41586-019-1019-4
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of KDM2B epigenetic factor in regulating calcium signaling in prostate cancer cells;Saudi Pharmaceutical Journal;2024-07
2. The role of serum and glucocorticoid-regulated kinase 1 in cellular signaling: Implications for drug development;International Journal of Biological Macromolecules;2024-02
3. SGK1 is involved in doxorubicin-induced chronic cardiotoxicity and dysfunction through activation of the NFκB pathway;International Immunopharmacology;2023-12
4. Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses;Exploration of Targeted Anti-tumor Therapy;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3